| 标题 |
 Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet 作者：Edward B. Garon; Tudor–Eliade Ciuleanu; Óscar Arrieta; Kumar Prabhash; Konstantinos N. Syrigos; et al 出版日期：2014-06-02 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
璐璐
invisight
DW
v0id
林狗
aaaa
xing_xing
牧青
极限001
123
wangyumumu
pluto
渡人舟
aajhajkahna
wch666
谢雷XIELei
zd
学术文献互助
佚名
嘻嘻哈哈
皖公网安备34019202002308
